Study of Telitacicept in Generalized Myasthenia Gravis

A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.

NCT06447597 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

NCT07039916 ·Status: RECRUITING ·Phase: PHASE3

Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients

NCT05039190 ·Status: COMPLETED ·Phase: PHASE3

A Study in Patients With Myasthenia Gravis in China

NCT06700616 ·Status: ACTIVE_NOT_RECRUITING

A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

NCT03772587 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis

NCT05067348 ·Status: RECRUITING ·Phase: PHASE2

Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis

NCT02565576 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis

NCT05332210 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

NCT06517758 ·Status: RECRUITING ·Phase: PHASE3

An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis

NCT03896295 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis

NCT05332587 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

NCT06744920 ·Status: RECRUITING ·Phase: PHASE3

Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis

NCT00987116 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

NCT00727194 ·Status: TERMINATED ·Phase: PHASE2

A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

NCT07250750 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Tissue Repository for Studies of Myasthenia Gravis

NCT02902536 ·Status: COMPLETED

Methimazole to Treat Polymyositis and Dermatomyositis

NCT00001421 ·Status: COMPLETED ·Phase: PHASE2

Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis

NCT05403541 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis

NCT03052751 ·Status: COMPLETED ·Phase: PHASE2

A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis

NCT04963270 ·Status: TERMINATED ·Phase: PHASE3

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

NCT04225871 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

NCT00309101 ·Status: COMPLETED ·Phase: PHASE3

A Study of TACI（Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor）-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis

NCT04302103 ·Status: COMPLETED ·Phase: PHASE2

GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)

NCT07058298 ·Status: RECRUITING ·Phase: EARLY_PHASE1

A Prospective Cohort Study of Myasthenia Gravis in China

NCT06006832 ·Status: RECRUITING